Back to Invesco Ltd. Invesco Ltd.

NVAXNVAX

Showing 8 of 26 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in Novavax, Inc.

Yes. Invesco holds 236,004 shares of NVAX (Novavax), worth $2.2M, as of its Q2 2026 13F filing. It reduced the position by 28,850 shares (-10.9%) from Q1 2026. Invesco has held NVAX since Q1 2020, across 26 quarterly 13F filings.

Current Value

$2.2M

Current Shares

236,004

Total Value Change

-$9.2M

Total Shares Change

-669,163

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
236,004
-10.9%
$2.2M0.0%$9.42
0
2026-Q1
Increased
264,854
+2.1%
$2.2M0.0%$8.14
26
2025-Q4
Increased
259,380
+12.9%
$1.7M0.0%$6.72
29
2025-Q3
Decreased
229,676
-22.5%
$2M0.0%$8.67
0
2025-Q2
Increased
296,476
+4.3%
$1.9M0.0%$6.30
27
2025-Q1
Increased
284,122
+84.0%
$1.8M0.0%$6.41
40
2024-Q4
Decreased
154,425
-82.9%
$1.2M0.0%$8.04
0
2024-Q3
Increased
905,167
+484.1%
$11.4M0.0%$12.63
45

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used